Moderna to submit Covid-19 vaccine to FDA as full results show 94 ...

California's Governor Warns of 'Drastic Action' as Hospitals Near Crisis

Moderna applied for emergency F.D.A. authorization for its vaccine; the first shots could be given as early as Dec. 21. New York will not “live through the ...

FDA announces advisory committee meeting to discuss Moderna ...

The U.S. Food and Drug Administration on Monday announced it has scheduled a meeting this month to discuss the request for emergency use authorization ...

Despite 'mild reaction' to Moderna vaccine, CA trial participant ...

Pharmaceutical giant Moderna has applied for emergency use authorization of its coronavirus vaccine with the Food and Drug Administration on Monday.

Covid-19 : California's Governor Warns of 'Drastic Action' as ...

Moderna applied for emergency F.D.A. authorization for its vaccine; the first shots could be given as early as Dec. 21. New York will not “live through the ...

Covid-19 Live Updates: California's Governor Warns of 'Drastic ...

Moderna applied for emergency F.D.A. authorization for its vaccine; the first shots could be given as early as Dec. 21. New York will not “live through the ...

Moderna impulsa las esperanzas de tener una vacuna antes de ...

Las esperanzas de una primera ola de vacunación contra el covid-19 antes del final de 2020 recibieron un impulso de la empresa estadounidense Moderna, ...

ACTUALIZA 2-Moderna pide autorización de uso de vacuna en ...

(Amplía información). Por Julie Steenhuysen y Michael Erman. 30 nov (Reuters) - Moderna Inc solicitó el lunes la autorización de emergencia de Estados ...

Moderna se dispara 17% en Wall Street por resultados de su vacuna

Previo a la subida de este lunes, las acciones de Moderna ya habían acumulado un incremento de más del 500% en el año.

Covid-19 Live News and Updates

Moderna applied for emergency F.D.A. authorization for its vaccine; the first shots could be given as early as Dec. 21. New York will not “live through the ...

Moderna reporta una efectividad del 100% en su vacuna contra el ...

Las vacunas contra el coronavirus se han convertido en la esperanza de la humanidad, los países más avanzados en medicina trabajan arduamente para ...

Moderna to seek emergency authorization for COVID-19 vaccine

Drug maker Moderna announced today that it will request an emergency use authorization (EUA) from the Food and Drug Administration (FDA) for its COVID-19 ...

Moderna Asks Health Regulators to Authorize Its Covid-19 Vaccine

The drugmaker is seeking approval for its Covid-19 vaccine after it was shown to be 94.1% effective, keeping the shot on track for use in the U.S. by year's end, ...

'It's Like Star Trek': Moderna's Coronavirus Vaccine Moves Toward ...

Over the last year, the COVID-19 pandemic has been a trial by fire for Moderna's novel mRNA science, a technology that researchers describe as having ...

Nuevos estudios de Moderna informan que su vacuna tiene 94% de ...

(TELEMUNDO ATLANTA).- Un nuevo análisis reveló que la vacuna contra la COVID-19 de Moderna fue más del 94% efectiva en su ensayo clínico, y la ...

La vacuna de Moderna contra el coronavirus se llevará en ...

La distribución de la vacuna de covid-19 de Moderna será "típica" y no requerirá manipulación o almacenamiento especial, dijo el domingo a CNN el director ...

Moderna buscará el lunes autorización de emergencia de su ...

Moderna Inc dijo que pedirá el lunes la autorización de uso de emergencia en Estados Unidos y la Unión Europea de su vacuna contra el COVID-19, basada ...

Moderna to Ask Health Regulators to Authorize Its Covid-19 Vaccine

The drugmaker is seeking U.S. and European regulators' authorization for its Covid-19 vaccine after it was shown to be 94.1% effective, keeping it on track to go ...

Moderna's COVID-19 Vaccine Candidate Gets More Good News

The biotech company has new data reinforcing that its COVID-19 inoculation is safe and effective. Moderna is submitting an application to the FDA requesting ...

Moderna solicitará este lunes la autorización de emergencia para ...

El laboratorio Moderna informó que solicitará este lunes a los reguladores de EEUU y Europa que permitan el uso de emergencia de su vacuna COVID-19, ...

Moderna solicitará este lunes la autorización de la FDA para su ...

(CNN) — La compañía farmacéutica Moderna tiene la intención de solicitar este lunes a la Administración de Medicamentos y Alimentos de EE. UU. la ...

Moderna solicitará el lunes autorización para su vacuna de covid-19 ...

Washington (AFP). La estadounidense Moderna anunció que presentará este lunes solicitudes de autorización de emergencia para su vacuna contra el ...

Moderna to ask the FDA to greenlight its coronavirus vaccine

If the vaccine receives a green light, 20 million doses could be given by the end of the year.

Moderna pide a EEUU y la UE que usen su vacuna de emergencia ...

Varias candidatas a vacuna deben tener éxito para que el mundo ponga alto a la pandemia, que ha tomado un segundo aire en Estados Unidos y Europa.

Covid-19 vaccine: Moderna to apply today for FDA authorization ...

Pharmaceutical company Moderna intends to apply Monday to the US Food and Drug Administration for authorization of its Covid-19 vaccine.

Moderna Is Applying for Emergency F.D.A. Approval for Its ...

The first shots could be given as early as Dec. 21, if authorization is granted.

'Absolutely remarkable': No one who got Moderna's vaccine in trial ...

Science 's COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation. Continuing the spate of stunning news about COVID-19 ...

Moderna becomes second company to request emergency FDA ...

Moderna will be the second coronavirus vaccine maker to request authorization from the government after similarly positive trial results for Pfizer.

More Good News For Moderna's COVID-19 Vaccine Candidate

Biotech company Moderna has new data reinforcing that its COVID-19 inoculation is safe and effective. The company is submitting an application to the FDA ...

Moderna virus vaccine shows overwhelming success in tests

The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna's ongoing study. A week ago, competitor Pfizer Inc.

Moderna reports its COVID-19 vaccine is 94.5% effective in first data ...

Following fast on the heels of Pfizer's announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday.

Lo que significa para los demás ensayos médicos el anuncio de la ...

Moderna acaba de anunciar que su candidata a vacuna ha demostrado una eficacia de 94,5% para prevenir la infección del nuevo coronavirus.

Esto es lo que sabemos de la vacuna de Moderna contra el Covid ...

La vacuna de la farmacéutica Moderna puede almacenarse en refrigeradores comunes y tiene una efectividad del 94.5%

COVID Vaccine Excitement Builds as Moderna Reports Positive Result

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the ...

Moderna anunció que podrá producir hasta 20 millones de vacunas ...

El médico jefe de la farmacéutica, Tal Zaks, dijo que la decisión es consecuencia de la inversión de casi USD 1.000 millones del gobierno norteamericano en el ...

Moderna says its COVID-19 vaccine is 94.5 percent effective in early ...

Moderna, the first company to send a COVID-19 vaccine candidate to clinical trials in the US, has just announced early results that indicate its mRNA-based ...

'Truly striking': Covid-19 vaccine candidate 94.5 percent effective ...

Biotech company Moderna said on Monday that early analysis from its phase 3 trial shows its Covid-19 vaccine is 94.5 percent effective at preventing infection.

Moderna's coronavirus vaccine found to be nearly 95 percent ...

The announcement puts the United States on track to have two strikingly effective coronavirus vaccines available in coming weeks.

'Just beautiful': Another COVID-19 vaccine, from newcomer Moderna ...

Moderna's candidate mRNA vaccine protected most people from symptomatic or severe COVID-19, fueling greater optimism that the pandemic can be ended.

Covid-19 vaccine candidate 94.5 percent effective, Moderna says

Biotech company Moderna said on Monday that early analysis from its phase 3 trial shows its Covid-19 vaccine is 94.5 percent effective at preventing infection.

Moderna says their COVID-19 vaccine is 94.5 percent effective in ...

Moderna, the first company to send a COVID-19 vaccine candidate to clinical trials in the US, has just announced early results that indicate their mRNA-based ...

El laboratorio Moderna informó que su vacuna contra el COVID-19 ...

La fórmula de la farmacéutica estadounidense también requiere ser congelada, igual que la de Pfizer, pero se conserva hasta 30 días bajo refrigeración común.

Coronavirus: Moderna anunció que su vacuna tiene una efectividad ...

La empresa farmacéutica Moderna anunció que la vacuna que desarrolla para prevenir el coronavirus tiene casi 95 por ciento de eficacia. La compañ...

La vacuna contra el coronavirus de Moderna tiene una eficacia del ...

La vacuna Moderna tiene una efectividad del 94,5% contra el coronavirus, según los primeros datos publicados por la compañía el lunes. | Salud | CNN.

BBVA vende por 9.700 millones su negocio en EE UU y usará los ...

La compañía estadounidense asegura que su candidata llega al 94,% de efectividad La Agencia Europea del Medicamento anuncia el proceso de autorización ...

Early Data Show Moderna's Coronavirus Vaccine Is 94.5% Effective

Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available ...

Moderna: Covid vaccine shows nearly 95% protection

The results add to growing confidence that vaccination can end the pandemic.

'Just beautiful'—Another COVID-19 vaccine, from newcomer ...

Moderna's candidate mRNA vaccine protected most people from symptomatic or severe COVID-19, fueling greater optimism that the pandemic can be ended.

Moderna says preliminary trial data shows its coronavirus vaccine is ...

Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing Covid-19.

Moderna's coronavirus vaccine is 94.5% effective, according to ...

The Moderna vaccine is 94.5% effective against coronavirus, according to early data released Monday by the company, making it the second vaccine in the ...

Moderna's COVID-19 Vaccine Shines In Clinical Trial

Moderna's COVID-19 vaccine is nearly 95% effective in preventing illness, according to an interim analysis of a clinical test involving 30000 people.

Moderna stock soars following positive results in coronavirus ...

Moderna stock surged more than 14 percent in after-hours trading following positive results from the company's phase 1 study of its mRNA-1273 vaccine ...

Moderna's Covid Vaccine News Is Good. But Market-Moving Good?

Expanded trial results are promising, but there are a host of open questions about the vaccine's clinical and commercial potential.

Clinical trial shows Moderna COVID-19 vaccine on right track

Results from the phase 1 clinical trial of Moderna's coronavirus vaccine show it's on the right track, though there were serious side effects at high doses.

The First Covid Vaccine Tested in Humans by Moderna Shows ...

The vaccine, developed by government scientists and made by Moderna, a biotech company, appeared safe and provoked an immune response in 45 people in ...

Dow futures jump more than 200 points after Moderna says its ...

Stocks directly tied to an economic reopening jumped following the vaccine news.

Moderna's coronavirus vaccine produced antibodies in all patients ...

While stimulating production of neutralizing antibodies doesn't prove a vaccine will be effective, it's considered an important early step in testing.

Coronavirus live updates: Moderna says all patients produced ...

The coronavirus has infected more than 13.14 million people across the country as of Tuesday, killing at least 574600. people.

Moderna Phase one results show coronavirus vaccine safe, induces ...

Moderna Inc's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage ...

Moderna's COVID-19 jab spurs 'robust' immune response in first ...

Moderna's COVID-19 vaccine prompted an immune response similar to those seen in patients who have recovered from infection. Two weeks after receiving a ...

Dow futures jump 300 points after Moderna says its vaccine ...

Stock futures climbed higher in overnight trading on Tuesday after Moderna said its coronavirus vaccine produced antibodies in all patients in an early trial, ...

Moderna Coronavirus Vaccine Shows Promise in Key Early Trial

Moderna Inc.'s Covid-19 vaccine produced antibodies to the coronavirus in all patients tested in an initial safety trial, federal researchers said, clearing an ...

First data for Moderna Covid-19 vaccine show it spurs an immune ...

The study showed that vaccinated volunteers made more neutralizing antibodies than have been seen in most patients who have recovered from Covid-19.

Moderna coronavirus vaccine shows 'promising' results in published ...

A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health has been found to induce immune ...

Moderna Announces Publication in The New England Journal of ...

Moderna announces publication of interim results from Phase 1 study of its mRNA vaccine against COVID-19 (mRNA-1273) in NEJM.

Analyst Predicts Approval for Moderna's COVID-19 Vaccine

Shares of the vaccine maker Moderna (MRNA) are up by double digits in after-hours session Tuesday, thanks to a positive clinical update for its experimental ...

Moderna stock surges 17% on coronavirus vaccine trial news

Trial vaccine elicits 'robust' immune-system response in larger group of people, Moderna said.

Moderna vaccine produces antibodies in early trial

Moderna's potential Covid-19 vaccine produced immune responses in patients in the early stage trial, according to results published in a peer-reviewed journal ...

COVID-19 vaccine: Promising results from Moderna's first trial as ...

COVID-19 vaccine: Moderna is set to begin its phase 3 clinical trial on a coronavirus vaccine. It's the first phase 3 trial in the U.S..

Moderna Vaccine Produced Antibodies in All Patients Tested

Moderna Inc.'s Covid-19 vaccine produced antibodies to the coronavirus in all patients tested in an initial safety trial, federal researchers said, clearing an ...

Moderna shares jump as much as 16% after company says its ...

Moderna's potential vaccine to prevent Covid-19 produced neutralizing antibodies in all 45 patients in its early stage human trial, according to newly released ...

Moderna's Covid-19 Vaccine Moves to Bigger Study

A new U.S.-funded trial would seek 30000 subjects and could deliver an answer by year-end about whether the vaccine induces immune responses sufficient to ...

MIT professor's Moderna vaccine stake tops $1.4b

The value of board member Bob Langer's 3.2 per cent holding, including stock options, rose to $US934.3 million ($1.4 billion) on Monday.

MIT Professor's Moderna Stake on Brink of Topping

8 months ago by Bloomberg

Another early investor of Moderna Inc. is on the cusp of owning a stake worth at least $1 billion after the biotech firm reported encouraging early trial results for ...

Continue reading

White House coronavirus vaccine adviser Moncef Slaoui to divest ...

Newly appointed co-chair of the White House coronavirus vaccine project Moncef Slaoui plans to sell approximately $12.4 million worth of stock options in ...

Moderna: White House coronavirus vaccine leader is divesting

Former Moderna director Moncef Slaoui who now leads the White House's vaccine development effort will divest all of his equity interest, the company said.

Coronavirus czar to divest $10 million in Moderna stock options ...

Moncef Slaoui, the former Moderna board member who was tapped last week to lead "Operation Warp Speed," the White House's effort to quickly develop a ...

MIT Professor's Moderna Stake on the Brink of Topping

8 months ago by Bloomberg

Another early investor of Moderna Inc. is on the cusp of owning a stake worth at least $1 billion after the biotech firm reported encouraging early trial results for ...

Continue reading

Early results from Moderna coronavirus vaccine trial help to spark a ...

The Cambridge biotech said the initial results from the first phase of a clinical trial suggest that the vaccine « has the potential to prevent COVID-19 disease. »

Estadounidense Moderna: Proyecto de vacuna contra COVID ...

El compuesto produjo una respuesta inmune en ocho pacientes que la recibieron, de la misma magnitud de aquellos que se han contagiado con el virus, dijo la ...

Moderna's coronavirus vaccine shows encouraging early results

The eagerly-awaited data provide a first look at one of the eight vaccines worldwide that have begun human testing.

Acción de Moderna cierra en máximo histórico tras resultados de su ...

Las acciones de Moderna cerraron en un máximo histórico este lunes, luego de que su vacuna experimental contra el COVID-19 mostró resultados ...

Stocks rebound Monday as Moderna's coronavirus vaccine trial ...

Stocks bounced back Monday on optimism after drugmaker Moderna released promising early results for a coronavirus vaccine.

Los primeros resultados del ensayo de la vacuna de coronavirus ...

Los sujetos del estudio que recibieron la vacuna del covid-19 de Moderna tuvieron resultados tempranos positivos, según la compañía de biotecnología, que se ...

Acción de Moderna toca máximo histórico tras resultados de su ...

Las acciones de Moderna tocan un máximo histórico este lunes, luego de que su vacuna experimental contra el COVID-19 mostró resultados prometedores.

El Ibex rebota un 4,7% y se anota su mejor sesión desde finales de ...

Los inversores siguen a la caza de una empresa que encuentren una vacuna contra el Covid-19 y evite una nueva oleada del virus o un tratamiento que frene ...

Encouraging Vaccine Tests Let Moderna Think About Production

The Cambridge-based company is investing in manufacturing capacity in hopes of producing millions of doses of a COVID-19 vaccine.

Vacuna de Moderna contra COVID-19 muestra resultados ...

Por Saumya Joseph (Reuters) - Moderna Inc dijo el lunes que su vacuna experimental contra el COVID-19 mostró resultados prometedores en sus ...

Vacuna de Moderna contra el coronavirus, con resultados ...

Moderna Inc reportó que su vacuna experimental mRNA-1273 contra el coronavirus mostró resultados prometedores y espera pasar en julio a fase 2.

Moderna will spike another 25% from current levels after ...

Goldman Sachs lifted its price target for Moderna stock to $105 from $63 on Monday after first trials for its coronavirus drug showed 'encouragi...

Stocks soar on positive results from Moderna vaccine trial ...

Dow futures jump more than 650 points after the biotech company says its coroanvirus vaccine successfully produced covid-19 antibodies in all participants.

Moderna delivers first human data for a coronavirus vaccine

Moderna on Monday disclosed early results from a Phase 1 study of its experimental coronavirus vaccine, becoming the first company thus far to disclose human ...

Moderna Reveals 'Positive' Data In Coronavirus Vaccine Trial ...

Futures leaped in response at the possibility of a vaccine that could treat the virus.

'Great' Results: Moderna's Potential Coronavirus Vaccine Produced ...

CAMBRIDGE (CBS/CNN) — A Cambridge biotech company reported encouraging news Monday on its efforts to develop a potential coronavirus vaccine.

Moderna coronavirus vaccine: Early results from trial show ...

Study subjects who received Moderna's Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National ...

Moderna reports 'positive' results from early data on coronavirus ...

The biotech company Moderna on Monday reported “positive” data on its potential coronavirus vaccine from an early clinical trial, raising hopes about the effort.

Moderna Announces Positive Interim Phase 1 Data for its mRNA ...

mRNA-1273 elicited neutralizing antibody titer levels in all eight initial participants across the 25 µg and 100 µg dose cohorts, reaching or exceeding neutralizing ...

Moderna's COVID-19 vaccine shows positive results, moves to ...

Moderna's COVID-19 vaccine has positive results, shows it can produce an immune response to the coronavirus.

Early data show Moderna Covid-19 vaccine generates immune ...

The immune response is similar to the response seen in people who have been infected by the virus, known as SARS-CoV-2, and recovered.

Lonza Group shares climb on positive Moderna vaccine trial

Shares of Lonza Group undefined climbed 2.9% in Swiss trade after Moderna undefined reported positive interim clinical data of mRNA-1273, its vaccine...

Coronavirus vaccine: Early results from Moderna trial show ...

Study subjects who received Moderna's Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National ...

La vacuna contra el coronavirus del laboratorio norteamericano ...

Moderna Inc. informó este lunes que su vacuna experimental contra el COVID-19 mostró resultados prometedores en sus estudios iniciales y espera pasar en ...

Vacuna contra el coronavirus de Moderna dejó resultados positivos

La farmacéutica estadounidense aseguró que el "mRNA-1273" demostró ser "segura y bien tolerada". En julio trabajarán en la fase 3.

Moderna posts 'positive' early data for COVID-19 vaccine

Moderna's COVID-19 prompted an immune response similar to those seen in patients who have recovered from infection. Eight patients who received the two ...

Stocks rebound as positive Moderna vaccine trial boosts optimism ...

Stocks bounced back Monday on optimism the U.S. economy may start to recover from the coronavirus pandemic after drugmaker Moderna released promising ...

Farmacéutica Moderna obtiene datos 'muy positivos' de ensayo en ...

Moderna obtuvo datos reveladores de su posible vacuna contra el Covid-19 en 45 pacientes.

Suben 30% acciones de Moderna Inc tras anuncio sobre posible ...

La farmacéutica dijo hoy que las pruebas de una vacuna contra la pandemia arrojaron resultados prometedores en la primera fase de investigación.

Moderna skyrockets 39% after its early trial for a coronavirus vaccine ...

Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. Shares of the company su...

Moderna says first-stage study of coronavirus vaccine produced ...

The Cambridge biotech said the initial results from the first phase of a clinical trial suggest that the vaccine « has the potential to prevent COVID-19 disease. »

El BOE publica cómo es la fase 0,5 de Madrid, Barcelona y la mitad ...

Las acciones de la biotecnológica estadounidense suman más de un 30% con los mercados aún cerrados.

Vacuna de Moderna arroja resultados prometedores en primera ...

Moderna Inc dijo el lunes que su vacuna experimental mostró resultados prometedores en sus estudios iniciales y continúan investigación.

Coronavirus Vaccine From Moderna Shows Early Signs of Viral ...

An experimental vaccine from Moderna Inc. showed promising early signs that it can create an immune-system response in the body that could help fend off the ...

Coronavirus Vaccine Trial by Moderna Shows Promising Early Results

The company said its preliminary test in 8 healthy volunteers was safe. It is on an accelerated timetable to begin a larger human trial soon.

Moderna's coronavirus vaccine shows encouraging early results in ...

Moderna's announcement comes days after one of its directors, Moncef Slaoui, stepped down to become chief scientist for Operation Warp Speed, a White ...

Moderna reports positive data on early-stage coronavirus vaccine ...

Moderna said its early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all participants, sending its shares surging.